Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin K Dosing in Large Burns
NCT03941535Phase 4Unknown
- Sponsor
- Joseph M. Still Research Foundation
- Start
- May 2019
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, open-label trial of phytomenadione in burn injury (2 arms), sponsored by Joseph M. Still Research Foundation. Primary endpoint: Rate of Deep Vein Thrombosis occurrence at 90 days. Status: unknown.
02
Drugs
phytomenadione
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT03941535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03941535.